{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:13:38Z","timestamp":1789992818793,"version":"4.0.1"},"reference-count":161,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Dream-enactment behavior that emerges during episodes of rapid eye movement (REM) sleep without muscle atonia is a parasomnia known as REM sleep behavior disorder (RBD). RBD constitutes a prodromal marker of \u03b1-synucleinopathies and serves as one of the best biomarkers available to predict diseases such as Parkinson disease, multiple system atrophy and dementia with Lewy bodies. Most patients showing RBD will convert to an \u03b1-synucleinopathy about 10 years after diagnosis. The diagnostic advantage of RBD relies on the prolonged prodromal time, its predictive power and the absence of disease-related treatments that could act as confounders. Therefore, patients with RBD are candidates for neuroprotection trials that delay or prevent conversion to a pathology with abnormal \u03b1-synuclein metabolism. The administration of melatonin in doses exhibiting a chronobiotic\/hypnotic effect (less than 10 mg daily) is commonly used as a first line treatment (together with clonazepam) of RBD. At a higher dose, melatonin may also be an effective cytoprotector to halt \u03b1-synucleinopathy progression. However, allometric conversion doses derived from animal studies (in the 100 mg\/day range) are rarely employed clinically regardless of the demonstrated absence of toxicity of melatonin in phase 1 pharmacological studies with doses up to 100 mg in normal volunteers. This review discusses the application of melatonin in RBD: (a) as a symptomatic treatment in RBD; (b) as a possible disease-modifying treatment in \u03b1-synucleinopathies. To what degree melatonin has therapeutic efficacy in the prevention of \u03b1-synucleinopathies awaits further investigation, in particular multicenter double-blind trials.<\/jats:p>","DOI":"10.3390\/brainsci13050797","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:33:01Z","timestamp":1684139581000},"page":"797","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Melatonin as a Chronobiotic\/Cytoprotective Agent in REM Sleep Behavior Disorder"],"prefix":"10.3390","volume":"13","author":[{"given":"Daniel P.","family":"Cardinali","sequence":"first","affiliation":[{"name":"CENECON, Faculty of Medical Sciences, University of Buenos Aires, Buenos Aires C1431FWO, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Garay","sequence":"additional","affiliation":[{"name":"Unidad de Medicina del Sue\u00f1o-Secci\u00f3n Neurolog\u00eda, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Cl\u00ednicas \u201cNorberto Quirno\u201d (CEMIC), Buenos Aires C1431FWO, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"ref_1","unstructured":"(2015). American Academy of Sleep Medicine Darien IL The International Classification of Sleep Disorders, American Academy of Sleep Medicine."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.10730","article-title":"Retinal Involvement in Dementia with Lewy Bodies: A Clue to Hallucinations?","volume":"54","author":"Maurage","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and Predictors of Dementia and Parkinsonism in Idiopathic REM Sleep Behaviour Disorder: A Multicentre Study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12759","DOI":"10.1111\/jpi.12759","article-title":"Treatment of Isolated REM Sleep Behavior Disorder Using Melatonin as a Chronobiotic","volume":"71","author":"Kunz","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41582-021-00577-7","article-title":"Circadian Rhythms in Neurodegenerative Disorders","volume":"18","author":"Nassan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jsr.12371","article-title":"The Two-Process Model of Sleep Regulation: A Reappraisal","volume":"25","author":"Daan","year":"2016","journal-title":"J. Sleep. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e148288","DOI":"10.1172\/JCI148288","article-title":"Defining Circadian Disruption in Neurodegenerative Disorders","volume":"131","author":"Colwell","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-023-00340-6","article-title":"Circadian Disruption and Sleep Disorders in Neurodegeneration","volume":"12","author":"Shen","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.jmb.2019.12.036","article-title":"Molecular Connections Between Circadian Clocks and Aging","volume":"432","author":"Welz","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrg.2016.150","article-title":"Transcriptional Architecture of the Mammalian Circadian Clock","volume":"18","author":"Takahashi","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.jmb.2020.01.019","article-title":"Molecular-Genetic Manipulation of the Suprachiasmatic Nucleus Circadian Clock","volume":"432","author":"Hastings","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0092-8674(01)00610-9","article-title":"Posttranslational Mechanisms Regulate the Mammalian Circadian Clock","volume":"107","author":"Lee","year":"2001","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOL.0b013e3280464ef6","article-title":"The Orphan Nuclear Receptor Rev-Erb\u03b1: A Transcriptional Link between Circadian Rhythmicity and Cardiometabolic Disease","volume":"18","author":"Fontaine","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/0470090839.ch7","article-title":"Sehgal Orphan Nuclear Receptors, Molecular Clockwork, and the Entrainment of Peripheral Oscillators","volume":"253","author":"Preitner","year":"2003","journal-title":"Novartis Found. Symp."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"19240","DOI":"10.1038\/s41598-021-98532-5","article-title":"CHRONO and DEC1\/DEC2 Compensate for Lack of CRY1\/CRY2 in Expression of Coherent Circadian Rhythm but Not in Generation of Circadian Oscillation in the Neonatal Mouse SCN","volume":"11","author":"Ono","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_16","first-page":"26","article-title":"New Concepts in the Neurophysiology of Sleep and Wakefulness","volume":"9","author":"Garay","year":"2016","journal-title":"Physiol. Minirev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(82)90835-6","article-title":"Different Behaviors during Paradoxical Sleep without Atonia Depend on Pontine Lesion Site","volume":"239","author":"Hendricks","year":"1982","journal-title":"Brain. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","article-title":"Pathophysiology of REM Sleep Behaviour Disorder and Relevance to Neurodegenerative Disease","volume":"130","author":"Boeve","year":"2007","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1126\/science.7434029","article-title":"Human Sleep: Its Duration and Organization Depend on Its Circadian Phase","volume":"210","author":"Czeisler","year":"1980","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/sleep\/4.3.319","article-title":"Persistence of the Circadian Rhythm of REM Sleep: A Variety of Experimental Manipulations of the Sleep-Wake Cycle","volume":"4","author":"Endo","year":"1981","journal-title":"Sleep"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1523\/JNEUROSCI.20-11-04300.2000","article-title":"Circadian and Homeostatic Control of Rapid Eye Movement (REM) Sleep: Promotion of REM Tendency by the Suprachiasmatic Nucleus","volume":"20","author":"Wurts","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.5665\/sleep.2896","article-title":"REM Sleep Phase Preference in the Crepuscular Octodon Degus Assessed by Selective REM Sleep Deprivation","volume":"36","author":"Palacios","year":"2013","journal-title":"Sleep"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2869.2010.00848.x","article-title":"A Two-Part, Double-Blind, Placebo-Controlled Trial of Exogenous Melatonin in REM Sleep Behaviour Disorder","volume":"19","author":"Kunz","year":"2010","journal-title":"J. Sleep Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8","article-title":"Melatonin as a Therapy in REM Sleep Behavior Disorder Patients: An Open-Labeled Pilot Study on the Possible Influence of Melatonin on REM-Sleep Regulation","volume":"14","author":"Kunz","year":"1999","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","article-title":"Non-Motor Parkinson Disease: New Concepts and Personalised Management","volume":"208","author":"Titova","year":"2018","journal-title":"Med. J. Aust."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13966","DOI":"10.1111\/apha.13966","article-title":"Sleep and Circadian Rhythms in \u03b1-Synucleinopathies-Perspectives for Disease Modification","volume":"238","author":"Kunz","year":"2023","journal-title":"Acta Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/ejn.15859","article-title":"Chronobiology of Parkinson\u2019s Disease: Past, Present and Future","volume":"57","author":"Asadpoordezaki","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12264-021-00711-x","article-title":"Recent Progress in Non-Motor Features of Parkinson\u2019s Disease with a Focus on Circadian Rhythm Dysregulation","volume":"37","author":"Liu","year":"2021","journal-title":"Neurosci. Bull."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","article-title":"Delayed Emergence of a Parkinsonian Disorder or Dementia in 81% of Older Men Initially Diagnosed with Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A 16-Year Update on a Previously Reported Series","volume":"14","author":"Schenck","year":"2013","journal-title":"Sleep. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2018.07.019","article-title":"Circadian Rhythms of Melatonin and Peripheral Clock Gene Expression in Idiopathic REM Sleep Behavior Disorder","volume":"52","year":"2018","journal-title":"Sleep Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2009.02848.x","article-title":"Expression of Clock Genes Per1 and Bmal1 in Total Leukocytes in Health and Parkinson\u2019s Disease","volume":"17","author":"Cai","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neulet.2011.05.058","article-title":"Decreased Expression of Bmal2 in Patients with Parkinson\u2019s Disease","volume":"499","author":"Ding","year":"2011","journal-title":"Neurosci. Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and Circadian Rhythm Regulation in Early Parkinson Disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhong, G., Bolitho, S., Grunstein, R., Naismith, S.L., and Lewis, S.J.G. (2013). The Relationship between Thermoregulation and REM Sleep Behaviour Disorder in Parkinson\u2019s Disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072661"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1007\/s00415-013-6859-5","article-title":"Nocturnal Hypertension and Dysautonomia in Patients with Parkinson\u2019s Disease: Are They Related?","volume":"260","author":"Berganzo","year":"2013","journal-title":"J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejim.2006.02.020","article-title":"Characteristic Findings on 24-h Ambulatory Blood Pressure Monitoring in a Series of Patients with Parkinson\u2019s Disease","volume":"17","author":"Sekhon","year":"2006","journal-title":"Eur. J. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamaneurol.2020.1623","article-title":"Association of Circadian Abnormalities in Older Adults with an Increased Risk of Developing Parkinson Disease","volume":"77","author":"Leng","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/ane.13677","article-title":"Sleep Stability in Isolated Rapid Eye Movement Sleep Behavior Disorder, Parkinson\u2019s Disease, and Dementia with Lewy Bodies","volume":"146","author":"Bugalho","year":"2022","journal-title":"Acta. Neurol. Scand."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41531-022-00316-9","article-title":"Neuroimaging Evidence of Glymphatic System Dysfunction in Possible REM Sleep Behavior Disorder and Parkinson\u2019s Disease","volume":"8","author":"Si","year":"2022","journal-title":"NPJ. Park. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.adc8810","article-title":"A Mesothelium Divides the Subarachnoid Space into Functional Compartments","volume":"379","author":"Beinlich","year":"2023","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1093\/brain\/awp244","article-title":"Markers of Neurodegeneration in Idiopathic Rapid Eye Movement Sleep Behaviour Disorder and Parkinson\u2019s Disease","volume":"132","author":"Postuma","year":"2009","journal-title":"Brain"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1212\/WNL.0000000000200235","article-title":"Neuroprotective Trials in REM Sleep Behavior Disorder: The Way Forward Becomes Clearer","volume":"99","author":"Postuma","year":"2022","journal-title":"Neurology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An Essay on the Shaking Palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0079-6123(08)63582-7","article-title":"Paradoxical Sleep\u2014A Study of Its Nature and Mechanisms","volume":"18","author":"Jouvet","year":"1965","journal-title":"Prog. Brain. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0031-9384(79)90344-5","article-title":"Oneiric Behavior in Cats","volume":"22","author":"Sastre","year":"1979","journal-title":"Physiol. Behav."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/sleep\/9.2.293","article-title":"Chronic Behavioral Disorders of Human REM Sleep: A New Category of Parasomnia","volume":"9","author":"Schenck","year":"1986","journal-title":"Sleep"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1474-4422(21)00201-5","article-title":"Identifying the Best Biomarkers for \u03b1-Synucleinopathies","volume":"20","author":"Dauvilliers","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-018-0016-5","article-title":"REM Sleep Behaviour Disorder","volume":"4","author":"Dauvilliers","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp-2020-322875","article-title":"Clinical Trials in REM Sleep Behavioural Disorder: Challenges and Opportunities","volume":"91","author":"Videnovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0163-7258(95)02020-9","article-title":"Chronobiotics-Drugs That Shift Rhythms","volume":"69","author":"Dawson","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.sleep.2006.11.013","article-title":"Circadian Rhythm Sleep Disorders in the Blind and Their Treatment with Melatonin","volume":"8","author":"Skene","year":"2007","journal-title":"Sleep. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s40265-017-0707-3","article-title":"Diagnosis and Treatment of Non-24-h Sleep-Wake Disorder in the Blind","volume":"77","author":"Emens","year":"2017","journal-title":"Drugs"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e12544","DOI":"10.1111\/jpi.12544","article-title":"Sleep Well. Untangling the Role of Melatonin MT1 and MT2 Receptors in Sleep","volume":"66","author":"Gobbi","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.smrv.2016.06.005","article-title":"Evidence for the Efficacy of Melatonin in the Treatment of Primary Adult Sleep Disorders","volume":"34","author":"Auld","year":"2017","journal-title":"Sleep. Med. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","article-title":"Physiological Effects of Melatonin: Role of Melatonin Receptors and Signal Transduction Pathways","volume":"85","author":"Trakht","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fendo.2019.00391","article-title":"Melatonin: Countering Chaotic Time Cues","volume":"10","author":"Arendt","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_57","first-page":"311","article-title":"Origin of Cerebrospinal Fluid Melatonin and Possible Function in the Integration of Photoperiod","volume":"61","author":"Tricoire","year":"2003","journal-title":"Reprod. Suppl."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1034\/j.1600-079X.2002.2e001.x","article-title":"Role of CSF in the Transport of Melatonin","volume":"33","author":"Reiter","year":"2002","journal-title":"J. Pineal Res."},{"key":"ref_59","first-page":"159","article-title":"Melatonin Binding Sites in Brain: Single or Multiple?","volume":"5","author":"Cardinali","year":"1991","journal-title":"Adv. Pineal Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0024-3205(83)90025-5","article-title":"Regional Concentrations of Melatonin in the Rat Brain in the Light and Dark Period","volume":"33","author":"Pang","year":"1983","journal-title":"Life. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/07420528.2021.2016794","article-title":"Melatonin Profile in Healthy, Elderly Subjects-A Systematic Literature Review","volume":"39","author":"Godfrey","year":"2022","journal-title":"Chronobiol. Int."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Tchekalarova, J., and Tzoneva, R. (2023). Oxidative Stress and Aging as Risk Factors for Alzheimer\u2019s Disease and Parkinson\u2019s Disease: The Role of the Antioxidant Melatonin. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24033022"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","article-title":"Extrapineal Melatonin: Sources, Regulation, and Potential Functions","volume":"71","author":"Escames","year":"2014","journal-title":"Cell. Mol. Life. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"44","DOI":"10.32794\/mr11250011","article-title":"Mitochondria: The Birth Place, Battle Ground and the Site of Melatonin Metabolism in Cells","volume":"2","author":"Tan","year":"2019","journal-title":"Melatonin Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.pneurobio.2010.12.004","article-title":"Melatonin-A Pleiotropic, Orchestrating Regulator Molecule","volume":"93","author":"Hardeland","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/bph.13950","article-title":"Melatonin Receptors: Molecular Pharmacology and Signalling in the Context of System Bias","volume":"175","author":"Cecon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00429-017-1439-6","article-title":"Melatonin Receptors: Distribution in Mammalian Brain and Their Respective Putative Functions","volume":"222","author":"Ng","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molbrainres.2005.01.002","article-title":"The Regional and Cellular Expression Profile of the Melatonin Receptor MT1 in the Central Dopaminergic System","volume":"136","author":"Uz","year":"2005","journal-title":"Mol. Brain Res."},{"key":"ref_70","first-page":"BR61-7","article-title":"Melatonin MT1 and MT2 Receptor Expression in Parkinson\u2019s Disease","volume":"16","author":"Adi","year":"2010","journal-title":"Med. Sci. Monat."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2012.01.040","article-title":"Melatonin Modulates Cytoskeletal Organization in the Rat Brain Hippocampus","volume":"511","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2174\/1871524918666180531083944","article-title":"Recent Findings in Melatonin Research and Their Relevance to the CNS","volume":"18","author":"Hardeland","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jpi.12019","article-title":"Analysis of the Daily Changes of Melatonin Receptors in the Rat Liver","volume":"54","author":"Venegas","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000127185","article-title":"Inhibitory Effect of Melatonin on Gonadotropin-Releasing Hormone-Induced Ca2+ Oscillations in Pituitary Cells of Newborn Rats","volume":"65","year":"1997","journal-title":"Neuroendocrinology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.32794\/mr11250025","article-title":"Are Melatonin Doses Employed Clinically Adequate for Melatonin-Induced Cytoprotection?","volume":"2","author":"Cardinali","year":"2019","journal-title":"Melatonin Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/nyas.14005","article-title":"The Role of Melatonin in Targeting Cell Signaling Pathways in Neurodegeneration","volume":"1443","author":"Shukla","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10571-019-00724-1","article-title":"Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence","volume":"40","author":"Tan","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10571-019-00720-5","article-title":"Melatonin and Parkinson Disease: Current Status and Future Perspectives for Molecular Mechanisms","volume":"40","author":"Tamtaji","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s00018-017-2609-7","article-title":"Melatonin as a Mitochondria-Targeted Antioxidant: One of Evolution\u2019s Best Ideas","volume":"74","author":"Reiter","year":"2017","journal-title":"Cell. Mol. Life. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zhang, J., and Shi, Y. (2022). In Search of the Holy Grail: Toward a Unified Hypothesis on Mitochondrial Dysfunction in Age-Related Diseases. Cells, 11.","DOI":"10.3390\/cells11121906"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Bazzani, V., Equisoain Redin, M., McHale, J., Perrone, L., and Vascotto, C. (2022). Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911391"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","article-title":"Mitochondria, Oxygen Free Radicals, Disease and Ageing","volume":"25","author":"Raha","year":"2000","journal-title":"Trends. Biochem. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1743-7075-2-22","article-title":"Melatonin, a Potent Agent in Antioxidative Defense: Actions as a Natural Food Constituent, Gastrointestinal Factor, Drug and Prodrug","volume":"2","author":"Hardeland","year":"2005","journal-title":"Nutr. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/ENDO:27:2:119","article-title":"Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance","volume":"27","author":"Hardeland","year":"2005","journal-title":"Endocrine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1568026023394344","article-title":"Melatonin, Mitochondrial Homeostasis and Mitochondrial-Related Diseases","volume":"2","author":"Castroviejo","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10522-022-10006-x","article-title":"Therapeutic Potential of Melatonin and Its Derivatives in Aging and Neurodegenerative Diseases","volume":"24","author":"Verma","year":"2023","journal-title":"Biogerontology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Mor\u00e9n, C., de Souza, R.M., Giraldo, D.M., and Uff, C. (2022). Antioxidant Therapeutic Strategies in Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169328"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Chen, D., Zhang, T., and Lee, T.H. (2020). Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules, 10.","DOI":"10.3390\/biom10081158"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Reiter, R.J., Tan, D.X., Rosales-Corral, S., Galano, A., Jou, M.J., and Acuna-Castroviejo, D. (2018). Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082439"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbrc.2016.07.103","article-title":"Alpha-Synuclein and Beta-Amyloid-Different Targets, Same Players: Calcium, Free Radicals and Mitochondria in the Mechanism of Neurodegeneration","volume":"483","author":"Angelova","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.2147\/JIR.S334423","article-title":"Melatonin as a Potential Regulator of Oxidative Stress, and Neuroinflammation: Mechanisms and Implications for the Management of Brain Injury-Induced Neurodegeneration","volume":"14","author":"Ikram","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/jpi.12267","article-title":"Melatonin: An Ancient Molecule That Makes Oxygen Metabolically Tolerable","volume":"59","author":"Manchester","year":"2015","journal-title":"J. Pineal. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/biof.23","article-title":"Melatonin: Signaling Mechanisms of a Pleiotropic Agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"BioFactors"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1152\/physiol.00034.2019","article-title":"Melatonin in Mitochondria: Mitigating Clear and Present Dangers","volume":"35","author":"Reiter","year":"2020","journal-title":"Physiology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-079X.2010.00819.x","article-title":"Melatonin or Silymarin Reduces Maneb- and Paraquat-Induced Parkinsons Disease Phenotype in the Mouse","volume":"50","author":"Singhal","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2014.09.005","article-title":"Mechanism of the Beneficial Effect of Melatonin in Experimental Parkinson\u2019s Disease","volume":"79","author":"Yildirim","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.biopha.2018.12.101","article-title":"Emerging Pathways to Neurodegeneration: Dissecting the Critical Molecular Mechanisms in Alzheimer\u2019s Disease, Parkinson\u2019s Disease","volume":"111","author":"Tan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","article-title":"Understanding Dopaminergic Cell Death Pathways in Parkinson Disease","volume":"90","author":"Michel","year":"2016","journal-title":"Neuron"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuro.2021.11.011","article-title":"Role of Melatonin in TLR4-Mediated Inflammatory Pathway in the MTPT-Induced Mouse Model","volume":"88","author":"Yildirim","year":"2022","journal-title":"Neurotoxicology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e12525","DOI":"10.1111\/jpi.12525","article-title":"Melatonin and Inflammation\u2014Story of a Double-Edged Blade","volume":"65","author":"Hardeland","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms14048638","article-title":"Melatonin: Buffering the Immune System","volume":"14","author":"Lardone","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(80)90025-4","article-title":"Prostaglandin E Release by Rat Medial Basal Hypothalamus in Vitro. Inhibition by Melatonin at Submicromolar Concentrations","volume":"67","author":"Cardinali","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood-2005-09-3691","article-title":"Melatonin Suppresses Macrophage Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Expression by Inhibiting P52 Acetylation and Binding","volume":"108","author":"Deng","year":"2006","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Huang, L., Ren, Y., Zeng, Z., Ren, H., Li, S., He, S., He, F., and Li, X. (2019). Comparative Study of Striatum GABA Concentrations and Magnetic Resonance Spectroscopic Imaging in Parkinson\u2019s Disease Monkeys. BMC. Neurosci., 20.","DOI":"10.1186\/s12868-019-0522-8"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3389\/fneur.2018.00806","article-title":"Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease","volume":"9","author":"Baumann","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41467-018-03802-y","article-title":"GABAergic Inhibition in Dual-Transmission Cholinergic and GABAergic Striatal Interneurons Is Abolished in Parkinson Disease","volume":"9","author":"Lozovaya","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0149-7634(95)00052-6","article-title":"Melatonin Effects on Behavior: Possible Mediation by the Central GABAergic System","volume":"20","author":"Golombek","year":"1996","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpain.2008.08.007","article-title":"Preoperative Anxiolytic Effect of Melatonin and Clonidine on Postoperative Pain and Morphine Consumption in Patients Undergoing Abdominal Hysterectomy: A Double-Blind, Randomized, Placebo-Controlled Study","volume":"10","author":"Caumo","year":"2009","journal-title":"J. Pain"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1096\/fj.03-0739com","article-title":"Taurine Prevents the Neurotoxicity of \u0392-amyloid and Glutamate Receptor Agonists: Activation of GABA Receptors and Possible Implications for Alzheimer\u2019s Disease and Other Neurological Disorders","volume":"18","author":"Louzada","year":"2004","journal-title":"FASEB J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1254\/jphs.11183FP","article-title":"Melatonin Modulates the GABAergic Response in Cultured Rat Hippocampal Neurons","volume":"119","author":"Cheng","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-8993(97)00188-1","article-title":"Melatonin Administration Protects CA1 Hippocampal Neurons after Transient Forebrain Ischemia in Rats","volume":"755","author":"Cho","year":"1997","journal-title":"Brain. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1874360900901010023","article-title":"Neuroprotective Effect of Melatonin on Glucocorticoid Toxicity in the Rat Hippocampus","volume":"1","author":"Furio","year":"2014","journal-title":"Open. Physiol. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1096\/fasebj.10.8.8666166","article-title":"Neuroprotection by Melatonin from Kainate-induced Excitotoxicity in Rats","volume":"10","author":"Giusti","year":"1996","journal-title":"FASEB J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2826.2004.01250.x","article-title":"Mechanisms of N-Methyl-D-Aspartate Receptor Inhibition by Melatonin in the Rat Striatum","volume":"16","author":"Escames","year":"2004","journal-title":"J. Neuroendocrinol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/17446651.2019.1631158","article-title":"New Insights into the Function of Melatonin and Its Role in Metabolic Disturbances","volume":"14","author":"Kuwabara","year":"2019","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/brain\/aws009","article-title":"Parkinson\u2019s Disease, Insulin Resistance and Novel Agents of Neuroprotection","volume":"136","author":"Limousin","year":"2013","journal-title":"Brain"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin Resistance and Parkinson\u2019s Disease: A New Target for Disease Modification?","volume":"145\u2013146","author":"Athauda","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","article-title":"Association between Diabetes and Subsequent Parkinson Disease: A Record-Linkage Cohort Study","volume":"91","author":"Goldacre","year":"2018","journal-title":"Neurology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1073\/pnas.1610371113","article-title":"Cross-Talk between Amyloidogenic Proteins in Type-2 Diabetes and Parkinson\u2019s Disease","volume":"113","author":"Horvath","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Surguchov, A., and Surguchev, A. (2022). Synucleins: New Data on Misfolding, Aggregation and Role in Diseases. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123241"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00401-018-1832-0","article-title":"Interaction of Amyloidogenic Proteins in Pancreatic \u03b2 Cells from Subjects with Synucleinopathies","volume":"135","author":"Marcilla","year":"2018","journal-title":"Acta. Neuropathol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.pbb.2011.06.026","article-title":"Melatonin Protects against Neurobehavioral and Mitochondrial Deficits in a Chronic Mouse Model of Parkinson\u2019s Disease","volume":"99","author":"Patki","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_123","first-page":"999","article-title":"Melatonin Prevents Dopaminergic Cell Loss Induced by Lentiviral Vectors Expressing A30P Mutant Alpha-Synuclein","volume":"28","author":"Baekelandt","year":"2013","journal-title":"Histol. Histopathol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3109\/10715762.2015.1027198","article-title":"Melatonin Is Protective against 6-Hydroxydopamine-Induced Oxidative Stress in a Hemiparkinsonian Rat Model","volume":"49","author":"Ozsoy","year":"2015","journal-title":"Free. Radic. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11011-013-9416-0","article-title":"Fish Oil, Melatonin and Vitamin E Attenuates Midbrain Cyclooxygenase-2 Activity and Oxidative Stress after the Administration of 1-Methyl-4-Phenyl-1,2,3,6- Tetrahydropyridine","volume":"28","author":"Ortiz","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"L\u00f3pez, A., Ortiz, F., Doerrier, C., Venegas, C., Fern\u00e1ndez-Ortiz, M., Aranda, P., D\u00edaz-Casado, M.E., Fern\u00e1ndez-Gil, B., Barriocanal-Casado, E., and Escames, G. (2017). Mitochondrial Impairment and Melatonin Protection in Parkinsonian Mice Do Not Depend of Inducible or Neuronal Nitric Oxide Synthases. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183090"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bpa.12369","article-title":"Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson\u2019s Disease","volume":"27","author":"Hoshi","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.parkreldis.2018.10.018","article-title":"CSF \u03b1-Synuclein Inversely Correlates with Non-Motor Symptoms in a Cohort of PD Patients","volume":"61","author":"Schirinzi","year":"2019","journal-title":"Parkinsonism Park. Relat. Disord."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1567205015666180411092551","article-title":"Melatonin Treatment Enhances A\u03b2 Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis","volume":"15","author":"Pappolla","year":"2018","journal-title":"Curr. Alzheimer. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin Regulates A\u03b2 Production\/Clearance Balance and A\u03b2 Neurotoxicity: A Potential Therapeutic Molecule for Alzheimer\u2019s Disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Hu, X., Li, J., Wang, X., Liu, H., Wang, T., Lin, Z., and Xiong, N. (2023). Neuroprotective Effect of Melatonin on Sleep Disorders Associated with Parkinson\u2019s Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12020396"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"650597","DOI":"10.3389\/fphar.2021.650597","article-title":"Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson\u2019s Disease","volume":"12","author":"Cardinali","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000119383","article-title":"Melatonin Effects in a Patient with Severe REM Sleep Behavior Disorder: Case Report and Theoretical Considerations","volume":"36","author":"Kunz","year":"1997","journal-title":"Neuropsychobiology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1440-1819.2001.00854.x","article-title":"Melatonin Therapy for REM Sleep Behavior Disorder","volume":"55","author":"Takeuchi","year":"2001","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1389-9457(03)00072-8","article-title":"Melatonin for Treatment of REM Sleep Behavior Disorder in Neurologic Disorders: Results in 14 Patients","volume":"4","author":"Boeve","year":"2003","journal-title":"Sleep Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.27492","article-title":"Drug Treatment of REM Sleep Behavior Disorder: The Use of Drug Therapies Other than Clonazepam","volume":"5","author":"Anderson","year":"2009","journal-title":"J. Clin. Sleep. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","article-title":"Treatment Outcomes in REM Sleep Behavior Disorder","volume":"14","author":"McCarter","year":"2013","journal-title":"Sleep. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1000118","DOI":"10.4172\/2167-0277.1000118","article-title":"Melatonin and REM Behavior Disorder","volume":"2","author":"Lin","year":"2013","journal-title":"J. Sleep Disord. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5665\/sleep.5332","article-title":"The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients","volume":"39","author":"Iranzo","year":"2016","journal-title":"Sleep"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1567205014666170523094938","article-title":"Melatonin Effects in REM Sleep Behavior Disorder Associated with Obstructive Sleep Apnea Syndrome: A Case Series","volume":"14","author":"Schaefer","year":"2017","journal-title":"Curr. Alzheimer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000488893","article-title":"Twenty Years after: Another Case Report of Melatonin Effects on REM Sleep Behavior Disorder, Using Serial Dopamine Transporter Imaging","volume":"76","author":"Kunz","year":"2018","journal-title":"Neuropsychobiology"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/acn3.753","article-title":"Prolonged-Release Melatonin in Patients with Idiopathic REM Sleep Behavior Disorder","volume":"6","author":"Jun","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27886","article-title":"Melatonin for Rapid Eye Movement Sleep Behavior Disorder in Parkinson\u2019s Disease: A Randomised Controlled Trial","volume":"35","author":"Gilat","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11325-022-02572-8","article-title":"Comparative Efficacy of Prolonged-Release Melatonin versus Clonazepam for Isolated Rapid Eye Movement Sleep Behavior Disorder","volume":"27","author":"Byun","year":"2023","journal-title":"Sleep Breath"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"689","DOI":"10.5664\/jcsm.5796","article-title":"An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder","volume":"12","author":"Esaki","year":"2016","journal-title":"J. Clin. Sleep Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2169\/internalmedicine.55.5464","article-title":"Beneficial Effects of Ramelteon on Rapid Eye Movement Sleep Behavior Disorder Associated with Parkinson\u2019s Disease-Results of a Multicenter Open Trial","volume":"55","author":"Kashihara","year":"2016","journal-title":"Intern. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2169\/internalmedicine.52.9179","article-title":"Use of Ramelteon for the Treatment of Secondary REM Sleep Behavior Disorder","volume":"52","author":"Nomura","year":"2013","journal-title":"Intern. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/JCP.0b013e31826866f8","article-title":"Agomelatine May Improve REM Sleep Behavior Disorder Symptoms","volume":"32","author":"Bonakis","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"769","DOI":"10.5664\/jcsm.10426","article-title":"Management of REM Sleep Behavior Disorder: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"19","author":"Howell","year":"2022","journal-title":"J. Clin. Sleep. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00415-020-10353-0","article-title":"A Critical Review of the Pharmacological Treatment of REM Sleep Behavior Disorder in Adults: Time for More and Larger Randomized Placebo-Controlled Trials","volume":"269","author":"Gilat","year":"2022","journal-title":"J. Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s41782-020-00111-7","article-title":"Elderly as a High-Risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration","volume":"4","author":"Cardinali","year":"2020","journal-title":"Sleep Vigil."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1517\/17425255.2014.934671","article-title":"The Application of Allometric Scaling Principles to Predict Pharmacokinetic Parameters across Species","volume":"10","author":"Huang","year":"2014","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jpi.12134","article-title":"Melatonin as a Potential Therapy for Sepsis: A Phase i Dose Escalation Study and an Ex Vivo Whole Blood Model under Conditions of Sepsis","volume":"56","author":"Galley","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","article-title":"The Safety of Melatonin in Humans","volume":"36","author":"Andersen","year":"2016","journal-title":"Clin. Drug. Investig."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.23652","article-title":"Trends in Use of Melatonin Supplements Among US Adults, 1999\u20132018","volume":"327","author":"Li","year":"2022","journal-title":"JAMA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s40263-019-00680-w","article-title":"Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review","volume":"33","author":"Besag","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e12782","DOI":"10.1111\/jpi.12782","article-title":"Safety of Higher Doses of Melatonin in Adults: A Systematic Review and Meta-Analysis","volume":"72","author":"Phillips","year":"2022","journal-title":"J. Pineal. Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"737972","DOI":"10.3389\/fpsyt.2022.737972","article-title":"The Therapeutic Effect of Exogenous Melatonin on Depressive Symptoms: A Systematic Review and Meta-Analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Psychiatry."},{"key":"ref_159","first-page":"1","article-title":"Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002\u20132012","volume":"79","author":"Clarke","year":"2015","journal-title":"Natl. Health Stat. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5664\/jcsm.6462","article-title":"Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content","volume":"13","author":"Erland","year":"2017","journal-title":"J. Clin. Sleep Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.5664\/jcsm.8896","article-title":"Hit or Miss: The Use of Melatonin Supplements","volume":"16","author":"Goldstein","year":"2020","journal-title":"J. Clin. Sleep Med."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/5\/797\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:34:34Z","timestamp":1760124874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/5\/797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":161,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["brainsci13050797"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13050797","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}